Metraipolis › archive › dc_aa3ee2084ece

SARS-CoV-2 Spike Protein as a Target of the COVID-19 Vaccine Disrupts Insulin Signaling in Type 2 Diabetes — Europe PMC PMID:41190280

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41190280
DOI
10.1002/mco2.70469
License (as archived)
solo-consultazione
Archived
2026-11-08T20:23:23.727Z
SHA-256 of the archived text
7b83ae9ae228a7476b01b9dc4b9b3f717488e7c42f6162414ea3c4b488c87f6a
Stable URL of this page
https://metraipolis.com/documento/dc_aa3ee2084ece

How to cite

SARS-CoV-2 Spike Protein as a Target of the COVID-19 Vaccine Disrupts Insulin Signaling in Type 2 Diabetes — Europe PMC PMID:41190280 — Europe PMC (en), https://europepmc.org/article/MED/41190280 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa3ee2084ece (Metraipolis archive dc_aa3ee2084ece, sha256 7b83ae9ae228a7476b01b9dc4b9b3f717488e7c42f6162414ea3c4b488c87f6a)
BibTeX
@misc{dcaa3ee2084ece,
  title = {SARS-CoV-2 Spike Protein as a Target of the COVID-19 Vaccine Disrupts Insulin Signaling in Type 2 Diabetes — Europe PMC PMID:41190280},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41190280},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa3ee2084ece; sha256 7b83ae9ae228a7476b01b9dc4b9b3f717488e7c42f6162414ea3c4b488c87f6a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41190280. Agents can read the archived copy with the MCP tool read_document.